tradingkey.logo
tradingkey.logo
検索

West Pharmaceutical Services Inc

WST
ウォッチリストに追加
338.430USD
+0.680+0.20%
取引時間 09/09, 10:26ET
23.83B時価総額
45.02直近12ヶ月PER

詳細情報 West Pharmaceutical Services Inc 企業名

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

West Pharmaceutical Services Inc プロフィール

企業コードWST
会社名West Pharmaceutical Services Inc
上場日Sep 01, 2059
最高経営責任者「CEO」Green (Eric Mark)
従業員数10600
証券種類Ordinary Share
決算期末Sep 01
本社所在地530 Herman O. West Drive
都市EXTON
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号19341
電話番号16105942900
ウェブサイトhttps://www.westpharma.com/
企業コードWST
上場日Sep 01, 2059
最高経営責任者「CEO」Green (Eric Mark)

West Pharmaceutical Services Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
179.49K
+4.66%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
45.42K
+1.74%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
44.31K
+1.79%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
43.66K
+1.65%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
22.75K
--
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.36K
+4.09%
Mr. Paolo Pucci
Mr. Paolo Pucci
Independent Director
Independent Director
10.78K
+7.34%
Mr. Robert F. (Rob) Friel
Mr. Robert F. (Rob) Friel
Independent Chairman of the Board
Independent Chairman of the Board
4.44K
+17.82%
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
3.52K
+22.45%
Ms. Janet Brutschea Haugen
Ms. Janet Brutschea Haugen
Independent Director
Independent Director
1.25K
+63.43%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
179.49K
+4.66%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
45.42K
+1.74%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
44.31K
+1.79%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
43.66K
+1.65%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
22.75K
--
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.36K
+4.09%

よくある質問

West Pharmaceutical Services Incの上位5名の株主は誰ですか?

West Pharmaceutical Services Incの上位5名の株主は以下のとおりです。Mr. Eric Mark Green

West Pharmaceutical Services Incの最大の収益源は何ですか?

2026Q4において、High Value Components部門がWest Pharmaceutical Services Incにとって最大の収益を生み出しており、その金額は427.43Mで、全収益の49.00%を占めています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。